← Home
/
Generate Biomedicines, Inc. (GENB)
Stock Analysis
Generate Biomedicines, Inc. (GENB)
GENB
GENB · Market data
13.87
+3.74%
Updated: 2026-06-18 13:33 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 16.22. Holding above 13.30 keeps the current thesis intact.
✓
Fundamentals
Insufficient / Negative
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
13.30
↗
Break Above
Confirmation improves above resistance.
16.22
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 13.30
What's Driving GENB?
📈 Technical recovery is improving
Momentum is Neutral. Watch 16.22 for confirmation and 13.30 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 13.30
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 0
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Insufficient
💵 Revenue
7.22M
≈ Insufficient
📈 Net Income
-61.45M
↘ Negative
🧮 EPS (Basic)
-1.07
↘ Negative
Generate Biomedicines, Inc.
Note: This is an algorithmic technical snapshot, not financial advice.